| Literature DB >> 33344228 |
Ming Yang1, Yong-Ran Cheng2, Meng-Yun Zhou2, Ming-Wei Wang3, Lan Ye4, Zu-Cai Xu5, Zhan-Hui Feng6, Xun-Tai Ma7.
Abstract
Meningiomas, the most common brain tumor, inevitably require surgical treatment. However, the efficacy of prophylactic antiepileptic drugs (AEDs), in reducing the frequency of new-onset seizures during the perioperative period remains controversial. To further clarify if prophylactic antiepileptic drug treatment for patients with meningioma had value, we reviewed the medical records of 186 supratentorial meningioma patients who were operated at our hospital between 2016 and 2018. SPSS 24.0 software was used for statistical analysis. The results of univariate analysis showed that factors including age, sex, the course of the disease (years), maximum cross-sectional area of the tumor, location of the tumor, multiple or single tumors, adjacent to the cortex, peritumoral brain edema, World Health Organization classification, and peritumoral adhesion were not associated with perioperative seizures (P >0.05). Furthermore, the results of multivariate analysis revealed hydrocephalus (OR 4.87 P = 0.05) and non-skull base location (OR 1.88 P = 0.04) were significant risk factors for perioperative in-hospital seizures. Prophylactic valproic acid treatment did not contribute to the alleviation of perioperative seizures (OR 1.76 P = 0.04). However, Multivariate logistic regression analyses excluding the patients with seizures before operation confirmed prophylactic valproic acid treatment did not reduce the frequency of seizures during the perioperative period (OR 1.84 P = 0.04). Taken together, the data suggest that prophylactic valproic acid treatment for patients with supratentorial meningioma does not reduce the rate of perioperative seizures.Entities:
Keywords: antiepileptic drugs; non-skull base location; operation; prophylactic treatment; seizure; supratentorial meningioma
Year: 2020 PMID: 33344228 PMCID: PMC7746868 DOI: 10.3389/fonc.2020.568369
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Flow chart of patients.
Baseline characteristics of participants.
| Variable | Seizure after operation | P value | |
|---|---|---|---|
| Yes | No | ||
| Age (years) at operation | 0.526 | ||
| ≥60 | 10/54 | 44/54 | |
| <60 | 30/132 | 102/132 | |
| Gender | 0.638 | ||
| male | 10/52 | 42/52 | |
| female | 30/134 | 104/134 | |
| Seizure before operation | 0.090 | ||
| Yes | 12/38 | 26/38 | |
| No | 28/148 | 120/148 | |
| The course of disease(years) | 0.983 | ||
| <1 | 31/146 | 115/146 | |
| 1–5 | 6/27 | 21/27 | |
| >5 | 3/13 | 10/13 | |
| Maximum cross-sectional area | 0.579 | ||
| ≤15 | 23/114 | 91/114 | |
| >15 | 17/72 | 55/72 | |
| Location of tumor | 0.032 | ||
| non-skull base location | 34/142 | 108/142 | |
| skull base location | 6/44 | 36/44 | |
| Multiple tumor | 0.502 | ||
| Yes | 3/10 | 7/10 | |
| No | 37/176 | 139/176 | |
| Adjacent to the cortex | 0.150 | ||
| Yes | 27/107 | 80/107 | |
| No | 13/79 | 66/79 | |
| Peritumoral brain edema | 0.149 | ||
| Yes | 27/108 | 81/108 | |
| No | 13/78 | 65/78 | |
| Hydrocephalus | 0.003 | ||
| yes | 7/13 | 6/13 | |
| No | 33/173 | 140/173 | |
| WHO classification | 0.245 | ||
| I level | 35/171 | 136/171 | |
| II/III level | 5/15 | 10/15 | |
| Peritumoral adhesion | 0.774 | ||
| Yes | 27/122 | 95/122 | |
| No | 13/64 | 51/64 | |
| AEDs | 0.021 | ||
| no | 7/80 | 73/80 | |
| Prophylactic treatment | 24/68 | 44/68 | |
| Treatment for seizure attack before operation | 9/38 | 29/38 | |
Figure 2Study population for a univariate logistic regression analyses.
Multivariate logistic regression analysis of study population.
| HR | CI 95% | P value | |
|---|---|---|---|
| Age | |||
| ≥60 | Reference | ||
| <60 | 0.86 | 0.24–6.35 | 0.48 |
| Gender | |||
| Male | Reference | ||
| Female | 1.02 | 0.45–4.23 | 0.54 |
| Hydrocephalus | |||
| No | Reference | ||
| Yes | 4.87 | 1.34–13.56 | 0.05 |
| Location of tumor | |||
| skull base location | Reference | ||
| non-skull base location | 1.88 | 1.43–11.34 | 0.04 |
| AEDs | |||
| No | Reference | ||
| Prophylactic treatment | 1.76 | 1.52–9.56 | 0.04 |
| Treatment for seizure attack before operation | 1.21 | 0.37–8.15 | 0.43 |
Baseline characteristics of participants excluding the patients with seizure attack before operation.
| Variable | Seizure after operation | P value | |
|---|---|---|---|
| Yes | No | ||
| Age (years) at operation | 0.600 | ||
| ≥60 | 7/43 | 36/43 | |
| <60 | 21/105 | 84/105 | |
| Gender | 0.257 | ||
| male | 5/39 | 34/39 | |
| female | 23/109 | 86/109 | |
| The course of disease(years) | 0.028 | ||
| <1 year | 22/118 | 96/118 | |
| 1–5years | 4/20 | 16/20 | |
| >5 years | 2/10 | 8/10 | |
| Maximum cross-sectional area | 0.384 | ||
| ≤15 | 15/90 | 75/90 | |
| >15 | 13/58 | 45/58 | |
| Location of tumor | 0.045 | ||
| non-skull base location | 33/108 | 75/108 | |
| skull base location | 6/40 | 34/40 | |
| Multiple tumor | 0.504 | ||
| Yes | 2/7 | 5/7 | |
| No | 26/141 | 115/141 | |
| Adjacent to the cortex | 0.756 | ||
| Yes | 17/86 | 69/86 | |
| No | 11/62 | 51/62 | |
| Peritumoral brain edema | 0.645 | ||
| yes | 15/86 | 71/86 | |
| no | 10/62 | 52/62 | |
| Hydrocephalus | 0.002 | ||
| yes | 6/11 | 5/11 | |
| No | 22/137 | 115/137 | |
| WHO classification | 0.575 | ||
| I level | 25/136 | 111/136 | |
| II/III level | 3/12 | 9/12 | |
| Peritumoral adhesion | 0.440 | ||
| yes | 17/99 | 82/99 | |
| no | 11/49 | 38/49 | |
| AEDs | 0.001 | ||
| no | 7/80 | 73/80 | |
| Prophylactic AED treatment | 21/68 | 47/68 | |
Figure 3Study population excluding the patients with seizure attack before operation for a univariate logistic regression analyses.
Multivariate logistic regression analysis of study population excluding the patients with seizure attack before operation.
| HR | CI95% | P value | |
|---|---|---|---|
| Age | |||
| ≥60 | Reference | ||
| <60 | 1.32 | 0.52–5.16 | 0.48 |
| Gender | |||
| Male | Reference | ||
| Female | 1.78 | 0.67–6.78 | 0.65 |
| Hydrocephalus | |||
| No | Reference | ||
| Yes | 5.12 | 1.45–9.56 | 0.04 |
| Location of tumor | |||
| skull base location | Reference | ||
| non-skull base location | 2.34 | 1.23–6.95 | 0.03 |
| AEDs | |||
| No | Reference | ||
| Prophylactic treatment | 1.84 | 1.35–5.21 | 0.04 |